Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stability

被引：0
|
作者：
Cullen, Matthew D. [1 ]
De Clercq, Erik [2 ]
Pannecouque, Christophe
Hartman, Tracy L. [3 ]
Buckheit, Robert W., Jr. [3 ]
Deng, Bo Liang [5 ]
Cushman, Mark [1 ,4 ]
机构：
[1] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA
[2] Katholieke Univ Leuven, Rega Inst Med Res, Johnson & Johnson Pharmaceut Res & Dev, B-3000 Louvain, Belgium
[3] Imquest Biosci Inc, Antiinfect Res, Frederick, MD 21704 USA
[4] Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA
[5] Nektar Therapeut, Huntsville, AL 35806 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2007年 / 233卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
72-MEDI
引用
收藏
页码：666 / 666
页数：1
相关论文
共 50 条
  • [1] Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stability
    Cullen, Matthew D.
    Deng, Bo-Liang
    Hartman, Tracy L.
    Watson, Karen M.
    Buckheit, Robert W., Jr.
    Pannecouque, Christophe
    De Clercq, Erik
    Cushman, Mark
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (20) : 4854 - 4867
  • [2] Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors
    Deng, BL
    Hartman, TL
    Buckheit, RW
    Pannecouque, C
    De Clercq, E
    Fanwick, PE
    Cushman, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (19) : 6140 - 6155
  • [3] Solid-phase synthesis of the alkenyldiarylmethane (ADAM) series of non-nucleoside HIV-1 reverse transcriptase inhibitors
    Xu, GZ
    Loftus, TL
    Wargo, H
    Turpin, JA
    Buckheit, RW
    Cushman, M
    JOURNAL OF ORGANIC CHEMISTRY, 2001, 66 (18): : 5958 - 5964
  • [4] Synthesis of alkenyldiarylmethane (ADAM) non-nucleoside HIV-1 reverse transcriptase inhibitors with non-identical aromatic rings
    Xu, GZ
    Hartman, TL
    Wargo, H
    Turpin, JA
    Buckheit, RW
    Cushman, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (02) : 283 - 290
  • [5] Non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Proudfoot, JR
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (08) : 971 - 982
  • [6] HIV-1 non-nucleoside reverse transcriptase inhibitors
    Högberg, M
    Morrison, I
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (08) : 1189 - 1199
  • [7] Synthesis and biological evaluation of (±)-benzhydrol derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors
    Ma, Xiao-Dong
    Zhang, Xuan
    Yang, Shi-Qiong
    Dai, Hui-Fang
    Yang, Liu-Meng
    Gu, Shuang-Xi
    Zheng, Yong-Tang
    He, Qiu-Qin
    Chen, Fen-Er
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (16) : 4704 - 4709
  • [8] Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors
    Yan, Zi-Hong
    Wu, Hai-Qiu
    Chen, Wen-Xue
    Wu, Yan
    Piao, Hu-Ri
    He, Qiu-Qin
    Chen, Fen-Er
    De Clercq, Erik
    Pannecouque, Christophe
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (12) : 3220 - 3226
  • [9] Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
    Zhan, Peng
    Liu, Xinyong
    Zhu, Junjie
    Fang, Zengjun
    Li, Zhenyu
    Pannecouque, Christophe
    De Clercq, Erik
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (16) : 5775 - 5781
  • [10] Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors
    Wang, Zhiwei
    Wu, Baogen
    Kuhen, Kelli L.
    Bursulaya, Badry
    Nguyen, Truc N.
    Nguyen, Deborah G.
    He, Yun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (16) : 4174 - 4177
12345